Title : Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate-mediated regulation of cullin-RING ligase and sensitize cancer cells to MLN4924/pevonedistat.

Pub. Date : 2020 Jul 24

PMID : 32493769






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Suramin and NF449 are IP5K inhibitors that disrupt IP6-mediated regulation of cullin RING ligase and sensitize cancer cells to MLN4924/pevonedistat. Phytic Acid inositol-pentakisphosphate 2-kinase Homo sapiens
2 Inositol hexakisphosphate (IP6) is an abundant metabolite synthesized from inositol 1,3,4,5,6-pentakisphosphate [Ins(1,3,4,5,6)P5, or IP5] by the single Ins(1,3,4,5,6)P5 2-kinase (IP5K/IPPK). Phytic Acid inositol-pentakisphosphate 2-kinase Homo sapiens
3 Inositol hexakisphosphate (IP6) is an abundant metabolite synthesized from inositol 1,3,4,5,6-pentakisphosphate [Ins(1,3,4,5,6)P5, or IP5] by the single Ins(1,3,4,5,6)P5 2-kinase (IP5K/IPPK). Phytic Acid inositol-pentakisphosphate 2-kinase Homo sapiens
4 Inositol hexakisphosphate (IP6) is an abundant metabolite synthesized from inositol 1,3,4,5,6-pentakisphosphate [Ins(1,3,4,5,6)P5, or IP5] by the single Ins(1,3,4,5,6)P5 2-kinase (IP5K/IPPK). Phytic Acid inositol-pentakisphosphate 2-kinase Homo sapiens
5 Inositol hexakisphosphate (IP6) is an abundant metabolite synthesized from inositol 1,3,4,5,6-pentakisphosphate [Ins(1,3,4,5,6)P5, or IP5] by the single Ins(1,3,4,5,6)P5 2-kinase (IP5K/IPPK). Phytic Acid inositol-pentakisphosphate 2-kinase Homo sapiens
6 Both suramin and NF449 disrupted IP6-dependent sequestration of CRL by the deneddylase COP9 Signalosome (CSN), thereby affecting CRL activity cycle and component dynamics in an IP5K-dependent manner. Phytic Acid inositol-pentakisphosphate 2-kinase Homo sapiens